The efficacy of combination treatment with elotuzumab and lenalidomide is dependent on crosstalk between natural killer cells, monocytes and myeloma cells
- Kelden Richardson
- , Simon P. Keam
- , Joe Jiang Zhu
- , Deborah Meyran
- , Criselle D’Souza
- , Sean Macdonald
- , Kerry Campbell
- , Michael Robbins
- , Natalie A. Bezman
- , Kirsten Todd
- , Hang Quach
- , David S. Ritchie
- , Simon J. Harrison
- , H. Miles Prince
- , Joseph A. Trapani
- , Misty R. Jenkins
- , Paul A. Beavis
- , Phillip K. Darcy
- , Paul J. Neeson
- Peter Maccallum Cancer Centre
- University of Melbourne
- Bristol-Myers Squibb
- St. Vincent's Hospital Melbourne
- Royal Melbourne Hospital
- Walter and Eliza Hall Institute of Medical Research
- La Trobe University
Research output: Contribution to journal › Article › peer-review
7
Scopus
citations